A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT03020797 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class

Stopped 1\) Enrolment below study target and 2) too many subjects had early termination due to disease progression.

Conditions

Interventions

Sponsor

Stony Brook University

Collaborators